[Body mass index in the prognosis of first myocardial infarction]

Miquel Fiol1, Rocío Amézaga, Fernando Arós

  • 1Ciber Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Palma de Mallorca, España. mfiol@hotmail.com

Medicina Clinica
|September 28, 2010
PubMed

Insights

Body mass index (BMI) is not a useful predictor for patients with ischemic heart disease. This study found BMI did not correlate with prognosis despite associations with other cardiovascular risk factors.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Research

Background:

  • The prognostic value of Body Mass Index (BMI) in ischemic heart disease (IHD) patients remains unclear.
  • Understanding BMI's role is crucial for risk stratification and patient management.

Purpose of the Study:

  • To investigate the association between BMI and cardiovascular risk factors.
  • To determine BMI's correlation with intra-hospital and 6-month mortality in IHD patients.

Main Methods:

  • Prospective, multicenter study with 1063 IHD patients (25-75 years old).
  • Data collected on demographics, anthropometrics, risk factors, and treatment.
  • Univariate and multivariate analyses performed for prognostic assessment.

Main Results:

  • Overweight and obesity (73.56% of patients) were linked to traditional risk factors (excluding smoking) and emergent factors.
  • BMI showed no significant association with short-term or mid-term prognosis.
  • No correlation found between BMI and patient mortality at 6 months.

Conclusions:

  • Body Mass Index (BMI) is not a reliable anthropometric measure for predicting prognosis in patients following a first myocardial infarction.
  • Clinical utility of BMI for post-MI risk assessment is limited.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...